This brief looks at premium changes for Medicare Part D stand-alone prescription drug plans between 2025 and 2026. For plans that were offered nationwide in 2025 and will continue to be offered in 2026, Part D enrollees in many states will see lower monthly premiums in 2026.
Here are three things healthcare leaders should consider for improving the DME process to make the hospital-to-home experience more efficient and less stressful for all stakeholders. The post From Hospital to Home Without the Headaches: How Technology Can Smooth the Transition appeared first on MedCity News.
The startup’s first disease target is chronic inflammatory demyelinating polyneuropathy (CIDP), which can be treated with a blockbuster Argenx drug. Nuvig aims to show its drug can offer a better way to treat this disease and other autoimmune conditions. The post Nuvig Therapeutics Nabs $161M to Build Case for a Better Approach to Autoimmune Disease…
These are the findings from the American Medical Association’s 2024 Physician Practice Benchmark Survey. Physicians included in the survey include those who practice in the U.S., actively see patients, and have completed residency. Here is what the survey finds: Increasingly, physicians are less likely to work in small practices that they or other physicians own….
Robert F. Kennedy Jr.’s confirmation hearings for secretary of Health and Human Services are happening Jan. 29 and Jan. 30, and KFF Health News reporters will be watching as the Senate Committee on Finance and the Senate Committee on Health, Education, Labor and Pensions ask Kennedy about everything from vaccines to abortion to Medicaid. What…
“Right To Try” experimental drug program saved “thousands and thousands of lives” Former President Donald Trump on Aug. 30 Former President Donald Trump has boasted in recent months about “Right To Try,” a law he signed in 2018. It’s aimed at boosting terminally ill patients’ access to potentially lifesaving medications not yet approved by the…
For years, White House press conferences included sign language interpreters for the deaf. No longer. Interpreters have been noticeably absent from Trump administration press briefings, advocacy groups say. Gone, too, are the American Sign Language interpretations that used to appear on the White House’s YouTube channel. A White House webpage on accessibility, whitehouse.gov/accessibility, has also…
Merck is acquiring global rights to a bispecific antibody from LaNova Medicines that blocks two cancer targets, PD-1 and VEGF. The deal comes one day after BioNTech announced an $800 million acquisition that gives it full rights to a molecule in this hot class of cancer drug candidates. The post Merck Is Paying $588M for…
By MIKE MAGEE This past week, Trump’s posting of himself as The Pope surfaced once again David French’s classic Christmas, 2024, New York Times column titled “Why Are So Many Christians So Cruel?” As I wrote at the time, “French and his wife and three children have experienced the cruelty first hand since he openly…
KFF Health News chief Washington correspondent Julie Rovner discussed Trump administration cuts to the National Institutes of Health on WNYC’s “The Brian Lehrer Show” on June 3. Click here to hear Rovner on “The Brian Lehrer Show.” KFF Health News Southern correspondent Sam Whitehead discussed Georgia’s abortion laws on WUGA’s “The Georgia Health Report” on May…